Physalin A
Based on 1 publication(s) in Google Scholar
Physalin A is a biologically active withanolide. Physalin A shows anti-inflammatory, antifibrotic and ameliorative effects on autophagy in models of disc degeneration. Physalin A has antitumor activity and can induce apoptosis, ROS production and G2/M phase cell cycle arrest. Besides. Physalin A can significantly increase the activity of quinone reductase and increase the expression of detoxifying enzymesc.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 99.63%
- CAS No.: 23027-91-0
- 화학식: C28H30O10
- 분자량:526.53
-
보관:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
-
Biological Activity
-
Chemical Information
- 순도&문서
- References
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) Physalin A
More
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HeLa | IC50 |
>50 μM
Compound: PA-2
|
Inhibition of TNFalpha-induced IkappaBalpha (unknown origin) phosphorylation expressed in human HeLa cells pretreated 30 mins before TNFalpha addition measured up to 120 mins by ELISA in presence of proteasome inhibitor MG-132
Inhibition of TNFalpha-induced IkappaBalpha (unknown origin) phosphorylation expressed in human HeLa cells pretreated 30 mins before TNFalpha addition measured up to 120 mins by ELISA in presence of proteasome inhibitor MG-132
|
[PMID: 24900739] |
| HeLa | IC50 |
22.7 μM
Compound: PA-2
|
Inhibition of TNFalpha-induced NF-kappaB activation (unknown origin) expressed in human HeLa cells pretreated 30 mins before TNFalpha addition after 7 hrs by luciferase reporter gene assay
Inhibition of TNFalpha-induced NF-kappaB activation (unknown origin) expressed in human HeLa cells pretreated 30 mins before TNFalpha addition after 7 hrs by luciferase reporter gene assay
|
[PMID: 24900739] |
| HT-1080 | IC50 |
10.7 μM
Compound: 1
|
Cytotoxicity against human HT1080 cells assessed as growth inhibition after 24 hrs by MTT assay
Cytotoxicity against human HT1080 cells assessed as growth inhibition after 24 hrs by MTT assay
|
[PMID: 23647462] |
| RAW264.7 | IC50 |
2.57 μM
Compound: 8
|
Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells assessed as nitrite formation
Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells assessed as nitrite formation
|
[PMID: 18348534] |
Physalin A (28.4 μM; 0-24 h) induces ROS production, G2/M phase cell cycle arrest and triggeres phosphorylation of P38 and ERK in A549 cells[2].
Physalin A (0-15 μM; 24 h) inhibits the cell viability and induces cell apoptosis in human non-small cell lung cancer[3].
Physalin A (20 μM; 48 h) improves TGF-β1-induced fibrosis in NP cells[4].
Physalin A (20 μM; 48 h) reduces inflammation by inhibiting NF-κB and MAPK signaling pathways and enhances autophagy by blocking PI3K/AKT/mTOR signaling pathways in IL-1β-treated NP cells[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:A549 cells
-
Concentration:28.4 μM
-
Incubation Time:6, 12 and 24 h
-
Result:Increased the phosphorylation levels P38 and ERK in a time-dependent manner.
-
Cell Line:H292, H358 and H1975 cells
-
Concentration:0, 2.5, 5, 10 and 15 μM
-
Incubation Time:24 h
-
Result:Increased the levels of apoptotic markers, such as cleaved poly(ADP-ribose) polymerase (PARP), cleaved caspase-3 and cleaved caspase-9.
-
Cell Line:NP cells were harvested from the inner tissue of tail disc of SpragueDawley rats
-
Concentration:20 μM
-
Incubation Time:48 h
-
Result:Reduced the phosphorylation levels of IKKα/β, IκBα and P65.
Reduced the phosphorylation levels of JNK, ERK and P38.
Reduced the phosphorylation levels of PI3K. AKT and mTOR.
Physalin A (2 μL 20 μM; Injection of nucleus pulposus of the disc; Single dose) has a protective effect in a rat model of disc degeneration[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male BALB/c mice[3]
-
Dosage:40 and 80 mg/kg
-
Administration:Intraperitoneal injection (i.p.); 10 days
-
Result:Significantly reduced the mean tumor volume and tumor weight, had the least effect on the weight of mice.
Decreased Tyr705-p-STAT3 levels, and increased caspase-3 activation.
-
Animal Model:Male Sprague-Dawley rats aged 6-8 weeks old (220±20 g) with intervertebral disc degeneration[4]
-
Dosage:2 μL 20 μM
-
Administration:Injection of nucleus pulposus of the disc; Single dose
-
Result:Alleviated disc degradation.
Reduced inflammation and fibrosis.
Chemical Information
-
CAS No. 23027-91-0
-
Appearance Solid
-
분자량 526.53
-
화학식 C28H30O10
-
Color White to off-white
-
SMILES
C[C@@]([C@@](OC1=O)([H])C2)(OC3=O)[C@@]([C@@]3(CC[C@@]([C@]45C)([H])[C@@]6([H])[C@@H](C=C4CC=CC5=O)O)O)(O[C@@]76O)[C@](C7=O)([H])[C@]2(C1=C)C
-
Structure Classification
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Immunopharmacol Immunotoxicol
2024 Nov 3:1-12. PMID: 39491800
순도&문서
-
Data Sheet (287 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[1]. Shin JM, et al. Physalin A regulates the Nrf2 pathway through ERK and p38 for induction of detoxifying enzymes. BMC Complement Altern Med. 2019 May 9;19(1):101. [Content Brief]
[2]. Kang N, et al. Physalin A induces G2/M phase cell cycle arrest in human non-small cell lung cancer cells: involvement of the p38 MAPK/ROS pathway. Mol Cell Biochem. 2016 Apr;415(1-2):145-55. [Content Brief]
[3]. Zhu F, et al. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling. Oncotarget. 2016 Feb 23;7(8):9462-76. [Content Brief]
[4]. Lu R, et al. Physalin A alleviates intervertebral disc degeneration via anti-inflammatory and anti-fibrotic effects. J Orthop Translat. 2023 Jan 25;39:74-87. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz